Advertisement
Screener

Insys Therapeutics, Inc. Increase (Decrease) in Accounts Receivable

Insys Therapeutics, Inc. Increase (Decrease) in Accounts Receivable

Insys Therapeutics, Inc. reported Increase (Decrease) in Accounts Receivable of -$6.52 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2019-05-13

  • Insys Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2019-03-31 was -$6.52M.
  • Insys Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2018-12-31 was -$107.00K.
  • Insys Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2018-09-30 was -$7.35M.
  • Insys Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2018-06-30 was $4.56M, a 57.26% decline year-over-year.
  • Insys Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2018 was -$8.90M, a 1136.44% decline from fiscal 2017.
  • Insys Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2017 was $859.00K.
  • Insys Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2016 was -$26.62M, a 211.98% decline from fiscal 2015.
  • Insys Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2015 was $23.77M, a 204.90% increase from fiscal 2014.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 3 month as first filedIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 9 month as first filedIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2019-03-31-$6.52M
10-Q · filed 2019-05-13
-$6.63M
derived: sum of 2 quarters · filed 2019-05-13
-$13.98M
derived: sum of 3 quarters · filed 2019-05-13
-$9.42M
derived: sum of 4 quarters · filed 2019-05-13
2018-12-31-$107.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$7.46M
derived: sum of 2 quarters · filed 2019-03-13
-$2.90M
derived: sum of 3 quarters · filed 2019-03-13
-$8.90M
10-K · filed 2019-03-13
2018-09-30-$7.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$2.79M
derived: sum of 2 quarters · filed 2018-11-09
-$8.80M
10-Q · filed 2018-11-09
-$10.53M
derived: sum of 4 quarters · filed 2019-05-13
2018-06-30$4.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$1.45M
10-Q · filed 2018-08-09
-$3.18M
derived: sum of 3 quarters · filed 2019-05-13
-$3.90M
derived: sum of 4 quarters · filed 2019-05-13
2018-03-31-$6.00M
10-Q · filed 2019-05-13
-$7.74M
derived: sum of 2 quarters · filed 2019-05-13
-$8.46M
derived: sum of 3 quarters · filed 2019-05-13
$2.20M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31-$1.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$2.46M
derived: sum of 2 quarters · filed 2019-03-13
$8.20M
derived: sum of 3 quarters · filed 2019-03-13
$859.00K
10-K · filed 2019-03-13
2017-09-30-$723.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$9.94M
derived: sum of 2 quarters · filed 2018-11-09
$2.60M
10-Q · filed 2018-11-09
-$10.31M
derived: sum of 4 quarters · filed 2019-03-13
2017-06-30$10.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$3.32M
10-Q · filed 2018-08-09
-$9.59M
derived: sum of 3 quarters · filed 2019-03-13
-$15.43M
derived: sum of 4 quarters · filed 2019-03-13
2017-03-31-$7.34M
10-Q · filed 2018-05-10
-$20.25M
derived: sum of 2 quarters · filed 2019-03-13
-$26.09M
derived: sum of 3 quarters · filed 2019-03-13
-$7.35M
derived: sum of 4 quarters · filed 2019-03-13
2016-12-31-$12.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$18.75M
derived: sum of 2 quarters · filed 2019-03-13
-$9.00K
derived: sum of 3 quarters · filed 2019-03-13
-$26.62M
10-K · filed 2019-03-13
2016-09-30-$5.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$12.90M
derived: sum of 2 quarters · filed 2017-11-03
-$13.71M
10-Q · filed 2017-11-03
-$14.55M
10-Q · filed 2016-11-03
$3.12M
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30$18.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
-$7.87M
10-Q · filed 2017-08-07
-$7.41M
10-Q · filed 2016-08-05
$8.96M
derived: sum of 3 quarters · filed 2018-03-12
$4.83M
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31-$26.61M
10-Q · filed 2017-05-09
-$27.50M
10-Q · filed 2016-05-05
-$9.77M
derived: sum of 2 quarters · filed 2018-03-12
-$13.91M
derived: sum of 3 quarters · filed 2018-03-12
-$10.95M
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31$16.84M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-12
$12.70M
derived: sum of 2 quarters · filed 2018-03-12
$15.65M
derived: sum of 3 quarters · filed 2018-03-12
$23.77M
10-K · filed 2018-03-12
$21.91M
10-K · filed 2016-02-29
2015-09-30-$4.13M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-04-07
-$1.18M
derived: sum of 2 quarters · filed 2017-04-07
$6.93M
10-Q/A · filed 2017-04-07
$3.93M
10-Q · filed 2015-11-05
$3.38M
derived: sum of 4 quarters · filed 2017-04-07
2015-06-30$2.96M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-04-07
$11.07M
10-Q/A · filed 2017-04-07
$12.61M
10-Q · filed 2015-08-06
$7.52M
derived: sum of 3 quarters · filed 2017-04-07
$19.49M
derived: sum of 4 quarters · filed 2017-04-07
2015-03-31$8.12M
10-Q/A · filed 2017-04-07
$7.63M
10-Q · filed 2015-05-11
$4.57M
derived: sum of 2 quarters · filed 2017-04-07
$16.54M
derived: sum of 3 quarters · filed 2017-04-07
$13.17M
derived: sum of 4 quarters · filed 2017-04-07
2014-12-31-$3.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-03
$8.42M
derived: sum of 2 quarters · filed 2017-04-03
$5.06M
derived: sum of 3 quarters · filed 2017-04-03
$7.80M
10-K · filed 2017-04-03
$10.23M
10-K · filed 2015-03-03
2014-09-30$11.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$8.61M
derived: sum of 2 quarters · filed 2015-11-05
$11.35M
10-Q · filed 2015-11-05
$15.28M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$3.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$626.00K
10-Q · filed 2015-08-06
$3.31M
derived: sum of 3 quarters · filed 2016-02-29
$6.56M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$2.74M
10-Q · filed 2015-05-11
$6.68M
derived: sum of 2 quarters · filed 2016-02-29
$9.92M
derived: sum of 3 quarters · filed 2016-02-29
$13.24M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$3.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$7.18M
derived: sum of 2 quarters · filed 2016-02-29
$10.50M
derived: sum of 3 quarters · filed 2016-02-29
$13.22M
10-K · filed 2016-02-29
2013-09-30$3.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$6.56M
derived: sum of 2 quarters · filed 2014-11-12
$9.29M
10-Q · filed 2014-11-12
$12.40M
derived: sum of 4 quarters · filed 2014-11-12
2013-06-30$3.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$6.04M
10-Q · filed 2014-08-12
$9.15M
derived: sum of 3 quarters · filed 2014-08-12
$5.62M
derived: sum of 4 quarters · filed 2014-08-12
2013-03-31$2.73M
10-Q · filed 2014-05-14
$5.84M
derived: sum of 2 quarters · filed 2014-05-14
$2.30M
derived: sum of 3 quarters · filed 2014-05-14
$3.51M
derived: sum of 4 quarters · filed 2014-05-14
2012-12-31$3.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05
-$424.00K
derived: sum of 2 quarters · filed 2014-03-05
$782.00K
derived: sum of 3 quarters · filed 2014-03-05
$3.09M
10-K · filed 2014-03-05
2012-09-30-$3.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$2.33M
derived: sum of 2 quarters · filed 2013-11-12
-$21.00K
10-Q · filed 2013-11-12
2012-06-30$1.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
$3.51M
10-Q · filed 2013-08-13
2012-03-31$2.31M
10-Q · filed 2013-06-05